Clinical efficacy of crizotinib in Chinese patients with ALK-positive non-small-cell lung cancer with brain metastases

BACKGROUND: Crizotinib has been associated with intracranial disease control in anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer (NSCLC) patients with brain metastases. Continued crizotinib treatment has also been used for prolonged disease control in patients experiencing isolat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Thorac Dis
Autors principals: Lei, Yuan-Yuan, Yang, Jin-Ji, Zhong, Wen-Zhao, Chen, Hua-Jun, Yan, Hong-Hong, Han, Jie-Fei, Yang, Lu-Lu, Wu, Yi-Long
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2015
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4522490/
https://ncbi.nlm.nih.gov/pubmed/26380734
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2015.06.04
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars